HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Expression of telomerase and p53 in ameloblastoma].

AbstractOBJECTIVE:
To detect the expression of p53 protein, hTR, and hTERT mRNA in ameloblastoma (AB) and to investigate the clinical biological characteristics of AB.
METHODS:
We detected hTR and hTERT Mrna in 54 cases of AB by in situ hybridization, and p53 protein by S-P method.
RESULTS:
The positive ratio of hTR, hTERT mRNA was 2/7 and 1/7 in normal oral mucosa, 81.2%(13/16) and 87.4% (14/16) in odontogenic keratocyst (OKC), 94.4%(51/54) in AB, respectively. There was a significant difference in these three groups (P < 0.001). A strong correlation between hTR and hTERT mRNA was found (rs = 1.000, P < 0.001). p53 protein was expressed in 87.5% (42/49) AB, 44%(11/25) OKC, 33.3%(1/3) normal oral mucosa, respectively. A strong correlation between hTERT mRNA and p53 protein was found (rs = 0.848, P < 0.001). A moderate correlation between hTR mRNA and p53 protein was found (rs = 0.536, P < 0.001).
CONCLUSION:
The positive ratios of hTR and hTERT were higher than p53 protein in AB. Telomerase activity and p53 expression play an important role in genesis and development of AB.
AuthorsMing Zhong, Lu-huang Zhang, Jie Wang, Bo Zhang, Lin Hou
JournalShanghai kou qiang yi xue = Shanghai journal of stomatology (Shanghai Kou Qiang Yi Xue) Vol. 12 Issue 2 Pg. 127-31 (Apr 2003) ISSN: 1006-7248 [Print] China
PMID14661519 (Publication Type: English Abstract, Journal Article)
Chemical References
  • DNA-Binding Proteins
  • RNA, Messenger
  • Tumor Suppressor Protein p53
  • Telomerase
Topics
  • Adolescent
  • Adult
  • Aged
  • Ameloblastoma (chemistry, etiology)
  • Child
  • DNA-Binding Proteins
  • Female
  • Humans
  • Immunohistochemistry
  • In Situ Hybridization
  • Jaw Neoplasms (chemistry, etiology)
  • Male
  • Middle Aged
  • Odontogenic Cysts (metabolism)
  • RNA, Messenger (analysis)
  • Telomerase (analysis, genetics)
  • Tumor Suppressor Protein p53 (analysis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: